Monografie
Pharmacological studies of a novel inhibitor of the mammalian target of rapamycin (mTOR) signaling pathway
- Language
-
Englisch
- Notes
-
München, Univ., Diss., 2010
- Identifier
-
1007186992
- Subject
-
Hochschulschrift
- Contributor
- URN
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
26.01.2023, 1:57 PM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Object type
- Monografie
Associated
Other Objects (12)
Effect of Akt (PKB) on the activity of mammalian target of rapamycin (mTOR)
Untersuchungen zur bestrahlungskombinierten Hemmung des mammalian target of rapamycin (mTOR) bei Glioblastomen
Die Rolle des "Protein Associated with Myc" (PAM) bei der Regulation des "mammalian Target Of Rapamycin" (mTOR) Signalweges
Regulation of mTOR signaling by amino acids and Rapamycin-FKBP complexes
Hemmung der Lymphangiogenese durch Inhibition des mammalian target of rapamycin
Inhibition des mammalian target of Rapamycin (mTOR) als mögliches Therapiekonzept des Urothelkarzinoms der Harnblase und der Plattenenpithelkarzinome des Kopf-Hals-Bereiches
Role of mammalian target of rapamycin complex 2 in primary and secondary liver cancer
Combining the receptor tyrosine kinase inhibitor AEE788 and the mammalian target of rapamycin (mTOR) inhibitor RAD001 strongly inhibits adhesion and growth of renal cell carcinoma cells
Identification of interacting partners of mammalian target of rapamycin complex 1 (mTORC1) assembly in human lymphocytes
The role of the kinase mechanistic Target Of Rapamycin – mTOR – and the RNA-binding protein Pumilio2 in epileptogenesis
Blocking mTOR signalling with rapamycin ameliorates imiquimod-induced psoriasis in mice
Pharmacological Cyclophilin inhibitors prevent intoxication of mammalian cells with Bordetella pertussis Toxin
Effect of Akt (PKB) on the activity of mammalian target of rapamycin (mTOR)
Untersuchungen zur bestrahlungskombinierten Hemmung des mammalian target of rapamycin (mTOR) bei Glioblastomen
Die Rolle des "Protein Associated with Myc" (PAM) bei der Regulation des "mammalian Target Of Rapamycin" (mTOR) Signalweges
Regulation of mTOR signaling by amino acids and Rapamycin-FKBP complexes
Hemmung der Lymphangiogenese durch Inhibition des mammalian target of rapamycin
Inhibition des mammalian target of Rapamycin (mTOR) als mögliches Therapiekonzept des Urothelkarzinoms der Harnblase und der Plattenenpithelkarzinome des Kopf-Hals-Bereiches
Role of mammalian target of rapamycin complex 2 in primary and secondary liver cancer
Combining the receptor tyrosine kinase inhibitor AEE788 and the mammalian target of rapamycin (mTOR) inhibitor RAD001 strongly inhibits adhesion and growth of renal cell carcinoma cells
Identification of interacting partners of mammalian target of rapamycin complex 1 (mTORC1) assembly in human lymphocytes
The role of the kinase mechanistic Target Of Rapamycin – mTOR – and the RNA-binding protein Pumilio2 in epileptogenesis
Blocking mTOR signalling with rapamycin ameliorates imiquimod-induced psoriasis in mice
Pharmacological Cyclophilin inhibitors prevent intoxication of mammalian cells with Bordetella pertussis Toxin
Effect of Akt (PKB) on the activity of mammalian target of rapamycin (mTOR)
Untersuchungen zur bestrahlungskombinierten Hemmung des mammalian target of rapamycin (mTOR) bei Glioblastomen
Die Rolle des "Protein Associated with Myc" (PAM) bei der Regulation des "mammalian Target Of Rapamycin" (mTOR) Signalweges
Regulation of mTOR signaling by amino acids and Rapamycin-FKBP complexes
Hemmung der Lymphangiogenese durch Inhibition des mammalian target of rapamycin
Inhibition des mammalian target of Rapamycin (mTOR) als mögliches Therapiekonzept des Urothelkarzinoms der Harnblase und der Plattenenpithelkarzinome des Kopf-Hals-Bereiches
Role of mammalian target of rapamycin complex 2 in primary and secondary liver cancer
Combining the receptor tyrosine kinase inhibitor AEE788 and the mammalian target of rapamycin (mTOR) inhibitor RAD001 strongly inhibits adhesion and growth of renal cell carcinoma cells
Identification of interacting partners of mammalian target of rapamycin complex 1 (mTORC1) assembly in human lymphocytes
The role of the kinase mechanistic Target Of Rapamycin – mTOR – and the RNA-binding protein Pumilio2 in epileptogenesis
Blocking mTOR signalling with rapamycin ameliorates imiquimod-induced psoriasis in mice